• General health care coverage and reimbursement; issues related to infectious disease drug development and procurement; legislative and regulatory issues related to biodefense countermeasure development and procurement; development of policies to advance the antimicrobial research and development environment. Support for H.R. 6294 - REVAMP Act.
• Medicare payment for inpatient antibiotics.

Duration: September 16, 2013 to November 10, 2018

General Issues: Health Issues, Medicare/Medicaid, Budget/Appropriations

Spending: about $800,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2013: U.S. Senate, House of Representatives, Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB)